Authentication
Sign In
Facebook Connect
Create account
Dashboard
Providers
Publications
Networks
Clusters
Virtual Clinics
Directories
ask Dr Jenny
Cancer
Cosmetic Surgery
Dentistry
Diabetes
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Haematology
Healthcare
Health Policy
Heart disease
Hepatology
Medical Technology
Medicine
Nephrology
Neurosurgery
Obstetrics and Gynaecology
Ophthalmology
Orthopaedics
Paediatrics
Palliative Care
Patients' Voices
Plastic and Reconstructive Surgery
Pregnancy & childbirth
Preventive medicine
Pulmonology
Radiotherapy
Rheumatology
STD
Urology
Vascular Disease
Weight Management
Library
You must log in to use
this feature.
My Account
Create account
Sign In
Facebook Connect
Details
Likes
0
Followers
2
Directory
Cancer
Expertise
analytical chemistry
drug design
drug development
drug discovery
EUTROC
medical chemistry
ovarian cancer
technological transfer
Sponsored
Maria Paola Costi
Full Professor in Medicinal Chemistry, Department of Life Science, University of Modena, Italy
Dipartimento di Scienze della Vita, via Giuseppe Campi, 287 41125 Modena
personale.unimore.it
About
Publications
Clusters
Organisations
10 years, 3 months ago
9198
0
Facebook
Twitter
Google+
LinkedIn
Report
Is tumor banking developed sufficiently to assemble the quantity and quality of appropriate data and tissue in a timely and effective way?
Maria Paola Costi
Directory:
Cancer
Tags:
biobanks
EUTROC
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
virtual tumor banks
view in full page